Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 3, 2017
Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG
Kozo Kataoka, Takahiro Kinoshita, Markus Moehler, et al.
Therapeutic Innovation & Regulatory Science
|
March 7, 2026
Challenges and Potential Solutions to Advance Global Cancer Drug Development
Axel Glasmacher, Kim Lyerly, Birgit Wolf, et al.
Journal of Geriatric Oncology
|
September 7, 2023
Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative
Angéline Galvin, Pierre Soubeyran, Etienne Brain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2015
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
Erik Tanis, Catherine Julié, Jean-Francois Emile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
BMC Cancer
|
May 26, 2019
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Anna Dorothea Wagner, Heike I Grabsch, Murielle Mauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2012
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials
Carine A Bellera, Marina Pulido, Sophie Gourgou, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers, Frits Van Coevorden, Cornelis J A Punt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
Markus Moehler, Maike Delic, Katrin Goepfert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 2022
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial
Solange Peters, Igor Letovanec, Murielle Mauer, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Gastric Cancer : Official Journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
|
February 3, 2017
Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG
Kozo Kataoka, Takahiro Kinoshita, Markus Moehler, et al.
Therapeutic Innovation & Regulatory Science
|
March 7, 2026
Challenges and Potential Solutions to Advance Global Cancer Drug Development
Axel Glasmacher, Kim Lyerly, Birgit Wolf, et al.
Journal of Geriatric Oncology
|
September 7, 2023
Assessing patient-reported outcomes (PROs) and patient-related outcomes in randomized cancer clinical trials for older adults: Results of DATECAN-ELDERLY initiative
Angéline Galvin, Pierre Soubeyran, Etienne Brain, et al.
European Journal of Cancer (Oxford, England : 1990)
|
September 7, 2015
Prognostic impact of immune response in resectable colorectal liver metastases treated by surgery alone or surgery with perioperative FOLFOX in the randomised EORTC study 40983
Erik Tanis, Catherine Julié, Jean-Francois Emile, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 15, 2010
Adjuvant gemcitabine alone versus gemcitabine-based chemoradiotherapy after curative resection for pancreatic cancer: a randomized EORTC-40013-22012/FFCD-9203/GERCOR phase II study
Jean-Luc Van Laethem, Pascal Hammel, Françoise Mornex, et al.
BMC Cancer
|
May 26, 2019
EORTC-1203-GITCG - the "INNOVATION"-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the perioperative treatment of HER2 positive, gastric and gastroesophageal junction adenocarcinoma on pathologic response rate: a randomized phase II-intergroup trial of the EORTC-Gastrointestinal Tract Cancer Group, Korean Cancer Study Group and Dutch Upper GI-Cancer group
Anna Dorothea Wagner, Heike I Grabsch, Murielle Mauer, et al.
European Journal of Cancer (Oxford, England : 1990)
|
November 6, 2012
Protocol of the Definition for the Assessment of Time-to-event Endpoints in CANcer trials (DATECAN) project: formal consensus method for the development of guidelines for standardised time-to-event endpoints' definitions in cancer clinical trials
Carine A Bellera, Marina Pulido, Sophie Gourgou, et al.
Journal of the National Cancer Institute
|
April 5, 2017
Local Treatment of Unresectable Colorectal Liver Metastases: Results of a Randomized Phase II Trial
Theo Ruers, Frits Van Coevorden, Cornelis J A Punt, et al.
European Journal of Cancer (Oxford, England : 1990)
|
April 4, 2016
Immunotherapy in gastrointestinal cancer: Recent results, current studies and future perspectives
Markus Moehler, Maike Delic, Katrin Goepfert, et al.
Lung Cancer (Amsterdam, Netherlands)
|
December 19, 2022
Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial
Solange Peters, Igor Letovanec, Murielle Mauer, et al.
Page
of 3